02.19.10
TSI Health Sciences, Inc., Missoula, MT, has obtained patent #7,645,466 for its ingredients Promilin and PromilinPro. The new, broad patented claim covers the methods for deriving, isolating and/or extracting amino acid compositions from Fenugreek seeds. The TSI patent covers the proprietary process for deriving novel compositions of bioactive compounds comprising 4-Hydroxyisoleucine, both for Promilin (20% 4-Hydroxyisoleucine) and PromilinPro (60% 4-Hydroxyisoleucine).